Metraipolis › archive › dc_64ac33dbbd23

Safety of Live Attenuated MMR, Varicella, and Yellow Fever Vaccination in Patients with Inflammatory Bowel Disease Receiving Biologic and Targeted Synthetic… — Europe PMC PMID:42347595

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42347595
DOI: 10.3390/vaccines14060474
License (as archived): solo-consultazione
Archived: 2026-11-01T07:18:58.103Z
SHA-256 of the archived text: fc94081287195cb4df7069601c854b2504c95cb5c253047df5c41b7f1d154422
Stable URL of this page: https://metraipolis.com/documento/dc_64ac33dbbd23

How to cite

Safety of Live Attenuated MMR, Varicella, and Yellow Fever Vaccination in Patients with Inflammatory Bowel Disease Receiving Biologic and Targeted Synthetic… — Europe PMC PMID:42347595 — Europe PMC (en), https://europepmc.org/article/MED/42347595 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64ac33dbbd23 (Metraipolis archive dc_64ac33dbbd23, sha256 fc94081287195cb4df7069601c854b2504c95cb5c253047df5c41b7f1d154422)

BibTeX

@misc{dc64ac33dbbd23,
  title = {Safety of Live Attenuated MMR, Varicella, and Yellow Fever Vaccination in Patients with Inflammatory Bowel Disease Receiving Biologic and Targeted Synthetic… — Europe PMC PMID:42347595},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42347595},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64ac33dbbd23; sha256 fc94081287195cb4df7069601c854b2504c95cb5c253047df5c41b7f1d154422},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42347595. Agents can read the archived copy with the MCP tool read_document.